Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Jul 21;14(7):e241154.
doi: 10.1136/bcr-2020-241154.

Omani experience with the use of factor IX Fc fusion protein

Shireen I Alzadjali  1   2 , Yasser Wali  3
Affiliations
Case Reports

Omani experience with the use of factor IX Fc fusion protein

Shireen I Alzadjali et al. BMJ Case Rep. .

Abstract

We describe our local experience in the management of haemophilia B patients with factor IX Fc fusion protein. Two children with haemophilia B were managed with the use of a personalised/tailored dosing schedule of factor IX Fc fusion protein. Compared with the standard half-life factor IX, prophylaxis with factor IX Fc fusion protein was cost-effective, with much less injections, better bleeding control, improved tolerability or no inhibitor development.

Keywords: congenital disorders; haematology (incl blood transfusion); paediatrics.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Similar articles

See all similar articles

References

    1. National Hemophila Foundation . Bleeding disorder, types of bleeding disorder (hemophilia B), 2019. Available: https://www.hemophilia.org/Bleeding-Disorders/Types-of-Bleeding-Disorder...
    1. Srivastava A, Brewer AK, Mauser-Bunschoten EP, et al. . Guidelines for the management of hemophilia. Haemophilia 2013;19:e1–47. 10.1111/j.1365-2516.2012.02909.x - DOI - PubMed
    1. Mannucci PM. Hemophilia therapy: the future has begun. Haematologica 2020;105:545–53. 10.3324/haematol.2019.232132 - DOI - PMC - PubMed
    1. Taylor JA, Kruse-Jarres R. A new era for hemophilia B treatment. Blood 2016;127:1734–6. 10.1182/blood-2016-02-694869 - DOI - PMC - PubMed
    1. Graf L. Extended half-life factor VIII and factor IX preparations. Transfus Med Hemother 2018;45:86–91. 10.1159/000488060 - DOI - PMC - PubMed

Publication types